CTC Detection Rate in SCCHN With a in Vivo Device

Enumeration and Molecular Characterization of Circulating Tumor Cells (CTCs) Using a in Vivo Device in Squamous Cell Carcinoma of Head and Neck (SCCHN)

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03071900

Enrollment

Registered

2017-03-07

Start date

2016-06-22

Completion date

2017-04-20

Last updated

2017-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulating Tumor Cell, Squamous Cell Carcinoma of the Head and Neck

Brief summary

Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.

Interventions

DIAGNOSTIC_TESTcirculating tumor cell analysis

Detect circulating tumor cells with CellCollector in SCCHN and control group.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* SCCHN confirmed with clinical examination * Have agreed to undergo CTC analysis in vivo; * ECOG：0-2

Exclusion criteria

* the other cancer types

Design outcomes

Primary

Measure	Time frame	Description
CTC isolation	9 month	Isolate circulating tumor cells in vivo with CellCollector

Countries

China

Contacts

Primary ContactZhenkun Yu, PhD

yuzk@njtrh.org+8625 66987199

Backup ContactHaidong Zhang, PhD

zhanghdent@163.com+86 1879598127

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026